相关实验视频

Updated: Jul 29, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

由于阿尔茨海默氏症病理学的认知衰退的超早期查

¹Beijing Key Laboratory of Rehabilitation Technical Aids for Old-Age Disability, Key Laboratory of Neuro-Functional Information and Rehabilitation Engineering of the Ministry of Civil Affairs, National Research Center for Rehabilitation Technical Aids, Beijing 100176, China.

|May 27, 2023

概括

早期发现过渡性认知衰退对于预防阿尔茨海默病至关重要. 开发新的查工具是必要的,以便在轻度认知障碍发展之前识别有风险的个体.

科学领域:

神经学神经学
老年学是一门学科.
生物标志物研究生物标志物研究

背景情况:

阿尔茨海默病 (AD) 病理的特征是粉样β (Aβ) 和生物标志物.
阿尔茨海默病的临床前阶段跨越了几十年,有效的治疗方法仍在开发中.
虽然发达国家痴呆率正在下降,但积极的干预措施至关重要.

研究的目的:

突出阿尔茨海默病早期干预的关键需求.
确定过渡性认知衰退作为比轻度认知障碍 (MCI) 更有效的干预窗口.
强调开发新的快速查工具的必要性,以早期检测认知衰退.

主要方法:

关于阿尔茨海默氏症病理学和认知衰退的当前研究的综述.
对针对轻度认知障碍 (MCI) 阶段的干预措施局限性的分析.
确定对新型认知查方法的需求.

主要成果:

一旦阿尔茨海默氏病理达到MCI阶段,干预措施可能会变得不那么有效.
患有MCI的个体恢复正常认知能力,很有可能发展为痴呆症.
在MCI之前的早期干预更有可能成功地阻断病理过程.

结论:

过渡性认知衰退代表了对阿尔茨海默病的干预的关键,早期窗口.
目前的认知测试主要集中在MCI上,需要开发新的工具来早期检测.
在MCI阶段之前采取主动措施对于保护认知功能和促进健康衰老至关重要.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.认知能力下降认知能力下降痴呆症痴呆症是一种痴呆症.超早期查超早期查

更多相关视频

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...